Key Takeaways Two Active Ingredients, Five Products GLP-1 Market Represents a Financialized Business Model Prolonged Patent Protection & Market Exclusivity Two Active Ingredients, Five Products: Semaglutide is marketed by Novo Nordisk as three separate drug products under the brand names: Ozempic (injection for diabetes, approved in 2017), Rybelsus (oral tablet for diabetes, approved in 2019), and Wegovy (injection for weight loss, approved in 2021)
Semaglutide/B6 + Glycine From $175/10mg Glycine-buffered semaglutide for patients who don't tolerate the B12 cofactor
The night I had my Violet Beauregarde bloating, the only thing I could do to stop the pressing pain was my go-to heartburn solution when all else fails
Int J Cardiol (2019) 292:21824
Some formulations have shorter room temperature stability, as few as 3 to 7 days
Micro-dosing provides those signals without overstimulation